2019 ICRT Conference Video

2019-08-22 11:37:00

Daily Programme

Day 1: Wednesday, August 21st, 2019

Time

Event

Location

08:00-17:00

Registration

Hotel Lobby (1st Floor)

17:30-18:30

The WARMTH EB and GB Meeting

Room 723 (7th Floor)

18:30-21:00

Welcome Reception

Baihua Hall (2nd Floor)

 

Day 2: Thursday, August 22nd, 2019

Location: Nanjing Hall (5th Floor)

Time

Speaker

Lecture Title

Opening Ceremony

08:30-08:40

Opening Remarks

08:40-08:43

Irene Virgolini

Welcome Speech

08:43-08:46

WARMTH Candle Lighting Ceremony

08:46-09:06

Mathew L. Thakur

Ajit Padhy Oration

09:06-09:09

WARMTH Lifetime Achievement Award to Professor Xiujie Liu

09:09-09:12

Yingdong Zhang

Welcome Speech

09:12-09:15

Hongbing Shen

Welcome Speech

09:15-09:18

Zhifang Chai

Welcome Speech

09:18-09:21

Amirreza Jalilian

Welcome Speech

09:21-09:24

Gang Huang

Welcome Speech

09:24-09:27

Yonghong Wang

Welcome Speech

09:27-09:30

Launching Ceremony

09:30-10:00

Small Concert

10:00-10:20

Coffee & Tea Break


Session 1: Theragnostics in Neuroendocrine Tumors

Chairman: Irene Virgolini, Sean Yan, Yaming Li

Time

Speaker

Lecture Title

10:20-10:40

Irene Virgolini

PRRT overview: The status and the state-of-the-art

10:40-11:00

Margarida Rodrigues

Multicenter retrospective analysis of Ga-68-DOTA-TOC/TATE and F-18-FDG-PET/CT in neuroendocrine tumor patients retreated with peptide receptor radionuclide therapy

11:00-11:20

Yaming Li

Impact of 18F-FDG PET/CT imaging on treatment of cancer

11:20-11:40

Jingjing Zhang

Peptide Receptor Radionuclide Therapy (PRRT) in Grade 3 (G3) Neuroendocrine Neopöasms (NEN): A Single Centre Experience

11:40-12:00

Duanmin Hu

The role of endoscopic ultrasound in pancreatic neuroendocrine tumors

12:30-13:30

Lunch


Session 4: The state-of-the-art Targeted Radiotherapy in Asia

Chairman: Seigo Kinuya, Lin Li

Time

Speaker

Lecture Title

12:30-12:45

Partha S Choudhary

The theragnostics in India

12:45-13:00

Seigo Kinuya

Theranostics in Japan

13:00-13:15

Sean Yan

PRRT - main stream practice and experience in an Asian centre

13:15-13:30

Lin Li

Brief introduction: current status of nuclear medicine in China

13:30-13:40

Hongyong Cao

Satellite Meeting (Perioperative nutrition support in patients with gastric cancer)


Session 5: Prostate Cancer

Chairman: J Harvey Turner, Richard P. Baum

Time

Speaker

Lecture Title

14:00-14:20

Weidong Yang

The clinic application of the 68Ga-PSMA PET imaging

14:20-14:40

J Harvey Turner

Theranostic outcomes in clinical oncology practice

14:40-15:00

Hojjat Ahmadzadehfar

617-Trial: retrospective multicentre analysis of castration refractory metastatic prostate cancer patients treated by 177Lu-PSMA-617

15:00-15:20

Masha Maharaj

A diagnostic and therapeutic approach to a patient with prostate cancer with special emphasis on radionuclide methods

15:20-15:40

Winnie Wing Chuen Lam

PSMA-based thera(g)nostics in prostate cancer, initial experience in Asian patients

15:40-16:00

Ali Cahid Civelek

Will PET-MRI take the place of PET/CT in prostate cancer

16:00-16:20

Coffee & Tea Break


Session 8: Thyroid Cancer

Chairman: Yansong Lin, Shuren Li

Time

Speaker

Lecture Title

16:20-16:40

Michael.kreissl

Radioiodine refractory differentiated thyroid cancer - Is there still an indication for radionuclide therapy?

16:40-17:00

Yansong Lin

Management of radioactive iodine refractory thyroid cancer

17:00-17:20

Libo Chen

Challenges and strategies on 131I treatment for differentiated thyroid carcinoma

17:20-17:40

Barbara Hertz

Dr Saul Hertz discovers the medical uses of radioiodine: challenges and legacy

17:40-18:00

Gang Qiu

Lung metastasis of thyroid cancer

18:00-20:00

Dinner

 

Location: Zhonghua Hall A (5th Floor)

Session 2: Summit and Workshop on Biomarker and Nuclear Medicine

Chairman: Yinglu Guo, Shukui Wang

Time

Speaker

Lecture Title

10:20-10:40

Amirreza Jalilian

The role of IAEA in supporting member states on radiopharmaceutical sciences

10:40-11:00

Xiaoyuan Chen

Evans blue modified radionuclide therapeutics

11:00-11:20

Jinliang Xing

Mitochondrial DNA mutation: transformation of a novel tumor biomarker

(线粒体DNA突变:一种新型肿瘤标志物的转化研究)

11:20-11:40

Yachao Liu

The value of PSMA PET in diagnosis and treatment of prostate cancer

(PSMA PET在前列腺癌诊断及治疗中的应用价值)

11:40-12:00

Shukui Wang

Screening, identification and application of novel tumor markers

(新型肿瘤标志物的筛选鉴定及应用进展)

12:30-13:30

Lunch



 

Session 6: Seminar on the Clinical Management of NET

Chairman: Zhenyu Zhang, Yuhong Zhou

Time

Speaker

Lecture Title

14:00-14:20

Yuan Ji

Pathological progression of neuroendocrine neoplasms

(神经内分泌肿瘤病理进展)

14:20-14:40

Liming Jiang

2019ENETS: Focus on imaging

(2019ENETS:聚焦影像学)

14:40-15:00

Hong Zhao

Surgical treatment strategy for MEN with liver metastasis

(神经内分泌肿瘤肝脏转移灶外科治疗策略)

15:00-15:20

Junli Wu

Precision surgical treatment of pancreatic neuroendocrine neoplasms

(胰腺神经内分泌肿瘤的精准外科治疗)

15:20-15:40

Yuhong Zhou

Advances in drug therapy for neuroendocrine tumors

(神经内分泌肿瘤药物治疗进展)

15:40-16:00

Qiyun Tang

The role of endoscopic images in neuroendocrine neoplasms

(内镜影像在神经内分泌肿瘤中的作用)

16:00-16:10

Coffee & Tea Break

16:10-16:30

Weijia Fang

Research progress of neuroendocrine tumor in China

(神经内分泌肿瘤中国学者研究进展)

16:30-16:50

Jingjing Zhang

20 years of PRRT experience (>6000 cycles) of a single center (Zentralklinik Bad Berka) - long-term outcome

(Zentralklinik Bad Berka单中心PRRT治疗20年经验(>6000 cycles)-基于长期随访结果)

16:50-17:00

Xiaochen Yao

The experience of diagnosis and treatment on nueroendocrine tumors in Nanjing First Hospital

(南京市第一医院神经内分泌肿瘤诊疗经验)

17:00-17:20

Wenbin Xu

Case discussion

17:20-17:40

Wenjia Liu

Case discussion

17:40-18:00

Discussion & Comments

18:00-20:00

Dinner


Location: Room 736 (7th Floor)

Continuing Education

Session 3: Cardiovascular and Cerebrovascular Diseases Room 736 (7th Floor)

Chairman: Yuetao Wang, Yihui Guan

Time

Speaker

Lecture Title

10:20-10:40

Dong Soo Lee

Brain theranostics

10:40-11:00

Yihui Guan

换成谢芳

Advance of molecular imaging techniques in central nervous system

11:00-11:20

Yuetao Wang

Interpretation of 2018 CSNM/CSC guidelines for the clinical use of cardiac radionuclide imaging

11:20-11:40

Lei Wang

Value of right heart imaging in pulmonary hypertension

11:40-12:00

Bailing Hsu

The recent advance of myocardial imaging quantitation in nuclear cardiology


Session 7: Workshop on Nuclear Medicine QC and Clinical Nursing

Chairman: Shuguang Chen, Kaixiu Zhang

Time

Speaker

Lecture Title

14:00-14:15

Tay Young Soon

Current approaches in dosimetry method and treatment delivery for neuroendocrine patients receiving radionuclide receptor therapy

14:15-14:30

Laurentcia Arlany

Radiation safety practices in radionuclide therapy

14:30-14:45

Josh Mailman

Theranostics in multidisciplinary care of oncology patients

14:45-15:00

Jingchen Jiang

Analysis of factors influencing myocardial metabolism imaging quality and countermeasures

15:00-15:15

Ning Li

131I-labeled BSA-CuS nanoparticles for radiotherapy and photothermal therapy to anaplastic thyroid carcinoma

15:15-15:30

Dongdong Huang

Effect of tube voltage and current on quantitative calculation of PET

15:30-15: 45

Wenrui Wang

SPECT quantitative analysis of coronary physiology: comparison with PET and application of SPECT in coronary microvascular dysfunction

15: 45-16:00

Hong Qu

To observe angiogenesis of rheumatoid arthritis and antagonist angiogenesis treatment by 99mTc-3PRGD2 imaging


 

Day 3: Friday, August 23rd, 2019

Location: Nanjing Hall (5th Floor)

Session 9: New Generation of Theragnostics

Chairman: Jun Hatazawa, Mingrong Zhang

Time

Speaker

Lecture Title

08:00-08:15

Richard P. Baum

Moving forward:novel theranostic strategies in neuroendocrine tumors

08:15-08:30

Jun Hatazawa

Possibility of Astatine-211 alpha particle therapy for intractable cancers combined with boron neutron capture therapy

08:30-08:45

Mingrong Zhang

211-At-labeled radiotracers: synthesis and preclinical evaluation

08:45-09:00

Ajit S. Shinto

Radioimmuno scintigraphy- biodistribution, pharmacokinetics and dosimetry in patients

09:00-09:15

Kalevi Kairemo

Phase I trial of Ra-223 and new NAFCIST response criteria in metastatic osteosarcoma

09:15-09:30

Knut Liepe

Radiosynovectomy in treatment of arthritis New guidelines for Radium-223

09:30-09:45

Kuangyu Shi

The potential of artificial intelligence in dosimetry-guided treatment planning of radioligand therapy

09:45-10:00

Xiaoqing Song

CIRC tumor theranostics and products

10:00-10:20

Coffee & Tea Break


Session 11: Hepatic Cellular Carcinoma Intervention

Chairman: David Ng, Sze Ting Lee

Time

Speaker

Lecture Title

10:20-10:40

Ajit S. Shinto

Rhenium project on liver cancer

10:40-11:00

David Chee Eng Ng

Y90 PET in SIRT

11:00-11:20

Sze Ting Lee

Molecular imaging of hypoxia in malignant diseases

11:20-11:40

Discussion

11:40-11:50

Peter Leitner

Satellite Meeting (Theranostics in a cyclotron radiopharmacy)

12:30-13:30

Lunch






Session 12: The Impact of PSMA Based Theragnostics (Clinical Perspective)

Chairman: Winnie Wing Chuen Lam, Bin Zhang

Time

Speaker

Lecture Title

12:30-12:45

Hongqian Guo

Perspective of urologist: Nanjing Drum Tower Hospital experience

12:45-13:00

Ruipeng Jia

Perspective of urologist: Nanjing First Hospital experience

13:00-13:15

Haiying Dong

Perspective of oncologist: Zhejiang Provincial People’s Hospital

13:15-13:30

Beihe Wang

Introducing PSMA into multimodality mangement of prostate cancer in Fudan University Shanghai Cancer Center

13:30-13:40

Alexander Pironi

Satellite Meeting ( ITM Isotopen Technologien München AG)


Session 13: Molecular Probe and Translations

Chairman: Xiaohua Zhu, Min Yang

Time

Speaker

Lecture Title

14:00-14:20

Shuren Li

Molecular imaging of tumor angiogenesis by using radionuclides: the past, present and future

14:20-14:40

Andreas Tuerler

225Ac and how to produce it

14:40-15:00

Min Yang

Brief introduction of GLP-1 derivatives and application

15:00-15:20

Chang Tong Yang

90Y-nanoparticle for liver tumor

15:20-15:40

Xiaohua Zhu

Tumor immune microenvironment and FDG uptake

15:40-16:00

Coffee & Tea Break



Session 16: PSMA Probe and beyond PSMA

Chairman: Shaoli Song, Ling Qiu

Time

Speaker

Lecture Title

16:00-16:20

Shankar Vallhabjoshula

PSMA targeted radionuclide therapy with antibodies and peptides: the past and the future

16:20-16:40

Jolanta Kunikowska

PSMA beyond prostate cancer

16:40-17:00

Xiang Li

Prostate membrane antigen (PSMA) biomarker for prostate cancer imaging and beyond

17:00-17:20

Discussion

 

Location: Zhonghua Hall A (5th Floor)

Session 10: Seminar on Digital PET/CT and PET/MRI/Global Summit of United Imaging

Chairman: Xu Huang

Time

Speaker

Lecture Title

08:00-09:00

Welcome ceremony

09:00-09:30

Dian Xiong

United imaging healthcare digital PET-CT introduction

09:30-10:00

Feng Wang

uMI 780/uPMR 790 user experience

10:00-10:20

Coffee & Tea Break

10:20-10:50

Yingwen Wei

uPMR 790/uEXPLORER introduction

10:50-11:20

Chenwei Li

uMI clinical application

11:20-11:40

Hongdi Li

Summary

12:30-13:30

Lunch


Session 14: Seminar on Prostate Cancer

Chairman: Zengjun Wang

Time

Speaker

Lecture Title

13:30-13:50

Satellite Meeting

14:00-14:20

Zengjun Wang/ Ruipeng Jia/ Feng Wang

Welcome speech

14:20-14:40

Marcus Hacker

Artificial intelligence in prostate cancer diagnostics

(人工智能在前列腺癌诊断中的应用)

14:40-15:00

Haiying Dong

Application of chemotherapy in prostate cancer

(化疗在前列腺癌中的应用)

15:00-15:20

Xuefeng Qiu

Postoperative pathologic changes of prostate cancer after neoadjuvant therapy

(新辅助治疗对于前列腺癌术后病理变化的报告)

15:20-15:40

Lixin Hua

Mechanism and benefit of novel first-line endocrine therapy in patients with high-risk mHSPC

(新型一线内分泌治疗方案治疗高危mHSPC患者的机制与获益)

15:40-16:00

Coffee & Tea Break

16:00-16:20

Yao Zhu

Iceberg or lighthouse: critical evaluation of PSMA imaging in prostate cancer

(冰山或灯塔:PSMA成像在前列腺癌中的重要评估)

16:20-16:40

Ruipeng Jia

Application of PSMA in prostate cancer

(PSMA在前列腺癌中的应用)

16:40-17:00

Discussion

17:00-17:20

Gong Cheng

MDT 1

17:20-17:40

Luwei Xu

MDT 2

17:40-18:00

Discussion and Summary


Official WeChat

Official WeChat

Official website of Nanjing Nuclear Medicine and academic conference on molecular markers and nuclear medicine targeted diagnostic therapy

Hospital headquarters Address: No. 68th Changle Road, Nanjing Qinhuai District; Guide Medical Hotline: +86 025-52275042 (8:00-20:00)

Copyright: International Conference On Radiopharmaceutical Therapy

E-mail:service@theranostics-nj.com

版权所有:南京临床核医学中心

苏ICP备11046759号-2